Cargando…
Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167542/ https://www.ncbi.nlm.nih.gov/pubmed/32381478 http://dx.doi.org/10.1016/j.vaccine.2020.04.037 |
| _version_ | 1783523582981177344 |
|---|---|
| author | Hosangadi, Divya Warmbrod, Kelsey Lane Martin, Elena K. Adalja, Amesh Cicero, Anita Inglesby, Thomas Watson, Crystal Watson, Matthew Connell, Nancy |
| author_facet | Hosangadi, Divya Warmbrod, Kelsey Lane Martin, Elena K. Adalja, Amesh Cicero, Anita Inglesby, Thomas Watson, Crystal Watson, Matthew Connell, Nancy |
| author_sort | Hosangadi, Divya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7167542 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71675422020-04-20 Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic Hosangadi, Divya Warmbrod, Kelsey Lane Martin, Elena K. Adalja, Amesh Cicero, Anita Inglesby, Thomas Watson, Crystal Watson, Matthew Connell, Nancy Vaccine Article Published by Elsevier Ltd. 2020-05-27 2020-04-20 /pmc/articles/PMC7167542/ /pubmed/32381478 http://dx.doi.org/10.1016/j.vaccine.2020.04.037 Text en © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Hosangadi, Divya Warmbrod, Kelsey Lane Martin, Elena K. Adalja, Amesh Cicero, Anita Inglesby, Thomas Watson, Crystal Watson, Matthew Connell, Nancy Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |
| title | Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |
| title_full | Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |
| title_fullStr | Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |
| title_full_unstemmed | Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |
| title_short | Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic |
| title_sort | enabling emergency mass vaccination: innovations in manufacturing and administration during a pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167542/ https://www.ncbi.nlm.nih.gov/pubmed/32381478 http://dx.doi.org/10.1016/j.vaccine.2020.04.037 |
| work_keys_str_mv | AT hosangadidivya enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT warmbrodkelseylane enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT martinelenak enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT adaljaamesh enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT ciceroanita enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT inglesbythomas enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT watsoncrystal enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT watsonmatthew enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic AT connellnancy enablingemergencymassvaccinationinnovationsinmanufacturingandadministrationduringapandemic |